In this interview, Didier discusses his projects and shares advice to the community regarding what kind of activities can help foster progress in the development of rejuvenation biotechnology.
Didier is one of the most active members of the European life extension community, co-president of HEALES (Healthy Life Extension Society), vice-president of French Transhumanist Association Technoprog, and a founding member of the International Longevity Alliance.
He is also a long-term member of the local ecology movement. Didier is currently a lawyer in a Belgian federal government agency for social security. Didier is the main organizer of the biennial scientific conference Eurosymposium on Healthy Ageing, held in Brussels, Belgium.
In this interview, he focused on the extension of healthy human life and the control of technological risks, the so called “existential risks”.
We appreciate Didier taking the time to share his vision with us and we are also grateful to him for his generous contributions to the research projects hosted at Lifespan.io.
Elena has been a longevity activist and advocate since 2013, when she first started to organize educational events to make new evidence-based methods of healthy life extension more popular.
The last few years have seen Elena leading some successful projects in Russia, aimed at spreading the idea of healthy longevity among decision makers as well as the general public. Several years of lobbying resulted in the inclusion of her propositions in the strategic program documents of the Russian Federation related to the problems of the elderly. She is a co-author of the book βAging Prevention for Allβ (in Russian, 2015), where, among other topics, she is sharing how to facilitate the adoption of the healthy lifestyle to promote the period of good health.
In 2015, Elena helped to shape and coordinate the successful crowdfunding campaign of theΒ Major Mouse Testing ProgramΒ β a study of Senolytic drug combinations on mouse lifespan.
In 2017 at LEAF, Elena led a successful advocacy project to include the problems of the elderly intoΒ the WHOβs 13th Programme of WorkΒ .
Previously Elena has worked as a project manager in the pharmaceutical and advertisement industries, helping to promote new drugs and therapies. This experience helped her to realize that the existing therapies were not 100% effective and could not completely stop age-related diseases β which has ignited an interest for the development of innovative therapies.
Elena graduated with a bachelorβs in both psychology and foreign languages and is now working to earn her MBA at the oldest Russian business school MIRBIS.
In his presentation at Ending Age-Related Diseases 2020, David Gobel of the Methuselah Foundation discusses current innovations in a historical context. He discusses a past […]
A professor at the University of Southern California has proposed that longevity researchers expand their toolkit to include social hallmarks of aging [1]. This paper is one of a trio that offer a […]
Rejuvenation biotechnology startup founder Kizoo has provided Elastrin, a company that focuses on removing calcification from tissue, with seed funding. The company […]
BioAge, in a recent press release, has announced the start of its phase 2a clinical trial in elderly patients with unexplained anemia. BioAge is a California-based company founded in 2015 with a […]
This week on Lifespan News, Brent Nally discusses longevity pharmacology, atrophy of the circadian clock, SIRT3 and lung fibrosis, research that suggests that we should look beyond biology to slow aging, and our Science to Save the World […]
Almost three years ago, Dr. Matt Kaeberlein, a Professor of Pathology and an Adjunct Professor of both Genome Sciences and Oral Health Sciences at the […]
In this episode of X10, we discuss three reasons why people don’t care about curing aging. Getting people to care about elderly dying from a deadly […]
You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.
Write a comment: